Global Addison’s Disease Market Size, Growth, Analysis, Trends, and Opportunities-2018
Summary: A new market study, titled “EPIOMIC EPIDEMIOLOGY SERIES: ADDISON’S DISEASE FORECAST IN 22 MAJOR MARKETS 2018–2028”, has been featured on WiseGuyReports. Report Description: The Epidemiology Forecast Report on Addison’s Disease in 22 Major Markets Addison’s disease (AD) is a chronic and rare endocrinal disorder, caused by destruction of the adrenal cortex which leads to the reduced production of glucocorticoids, mineralocorticoids and adrenal androgens. Chronic adrenal insufficiency and hypersecretion of ACTH is representative of the basic clinical signs and symptoms. AD can be part of the autoimmune polyglandular syndrome (PAS) (type 1 and 2), or it may present as an isolated disorder. PAS usually also affects other endocrine glands including the thyroid, pancreatic beta cells and stomach cells that allow absorption of vitamin B12 (producing pernicious anaemia). This report provides the current prevalent population for AD across 22 Major Markets (USA, Canada, Fr...